tert-Butyl ((1S,2S)-2-hydroxycyclohexyl)carbamate

Catalog No. :
ACGIEO306
CAS No. :
145166-06-9
Molecular Formula :
C11H21NO3
Molecular Weight :
215.29

IUPAC Name:tert-butyl ((1S,2S)-2-hydroxycyclohexyl)carbamate

tert-Butyl ((1S,2S)-2-hydroxycyclohexyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$98.00Login to see priceIn stockIn stock
25g98%$360.00Login to see priceIn stockIn stock
100g98%$1114.00Login to see priceInquiryInquiry
500g98%$4010.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl ((1S,2S)-2-hydroxycyclohexyl)carbamate
IUPAC Nametert-butyl ((1S,2S)-2-hydroxycyclohexyl)carbamate
MDL No.MFCD11042330
Molecular FormulaC11H21NO3
Molecular Weight215.29
SMILESO=C(OC(C)(C)C)N[C@@H]1[C@@H](O)CCCC1
InChI KeyXVROWZPERFUOCE-IUCAKERBSA-N
Synonym(1S,2S)-trans-N-Boc-2-aminocyclohexanol | (1S,2S)-trans-N-Boc-2-aminocyclohexanol, 95% | A850193 | 2-Methyl-2-propanyl [(1S,2S)-2-hydroxycyclohexyl]carbamate | tert-butyl (1S,2S)-2-hydroxycyclohexylcarbamate;tert-Butyl ((1S,2S)-2-hydroxycyclohexyl)carbama
CAS No.145166-06-9
PubChem CID10013520

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACGIEO306 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFABN376 route compound structure diagram
    ACFABN37613374-30-6 In Stock
  4. Then
  5. ACGIEO306 route product structure diagram
    ACGIEO306145166-06-9 In Stock
Inquiry

2. ACGIEO306 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGIEO306 route product structure diagram
    ACGIEO306145166-06-9 In Stock
Inquiry

Comments (0)